ABBOTT LABORATORIES — Director's Dealing 2007

Aug 13, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-08-09

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-09	Common shares without par value	M	9738	$43.73	Acquired	111865	Direct
2007-08-09	Common shares without par value	F	8421	$56.30	Disposed	103444	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-09	Option (right to buy)	$43.73	M	9738	Disposed	2008-02-12	Common Shares (9738)	Direct
2007-08-09	Option (right to buy)	$56.30	A	8421	Acquired	2008-02-12	Common Shares (8421)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15308	Indirect
Common shares without par value	25000	Indirect
Common shares without par value	885	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 9, 2007

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16a-(11)

F4: Reporting person disclaims beneficial ownership of all securities held by his son.

F5: Employee stock option, including a replacement option, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.